Syneron Medical (ELOS) Reports In-Line Q3 EPS

Syneron Medical (NASDAQ: ELOS) reported Q3 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $62.1 million versus the consensus estimate of $66.6 million.

For earnings history and earnings-related data on Syneron Medical (ELOS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance